Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
作者:
主题词
动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);联苄类(Bibenzyls);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌, 肝细胞(Carcinoma, Hepatocellular);细胞系, 肿瘤(Cell Line, Tumor);女(雌)性(Female);人类(Humans);肝肿瘤(Liver Neoplasms);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);纳米粒子(Nanoparticles);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.7150/thno.58164
PMID
33897892
发布时间
2024-08-09
- 浏览0

Theranostics
5955-5969页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文